<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0044">
 <label>44.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Sriramula</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xia</surname>
    <given-names>H</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xu</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lazartigues</surname>
    <given-names>E</given-names>
   </name>
  </person-group>
  <article-title>Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation</article-title>. 
  <source>Hypertens (Dallas, Tex 1979)</source>. 
  <year>2015</year>;
  <volume>65</volume>(
  <issue>3</issue>):
  <fpage>577</fpage>-
  <lpage>586</lpage>. doi:
  <pub-id pub-id-type="doi">10.1161/hypertensionaha.114.04691</pub-id>
 </mixed-citation>
</ref>
